Viewing Study NCT02283359


Ignite Creation Date: 2025-12-24 @ 2:49 PM
Ignite Modification Date: 2026-01-31 @ 5:13 AM
Study NCT ID: NCT02283359
Status: TERMINATED
Last Update Posted: 2016-01-15
First Post: 2014-11-03
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Selinexor in Combination With Irinotecan in Adenocarcinoma of Stomach and Distal Esophagus
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2014-12
Start Date Type: None
Primary Completion Date: 2015-12
Primary Completion Date Type: ACTUAL
Completion Date: 2016-01
Completion Date Type: ACTUAL
First Submit Date: 2014-11-03
First Submit QC Date: None
Study First Post Date: 2014-11-05
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2016-01-14
Last Update Post Date: 2016-01-15
Last Update Post Date Type: ESTIMATED